Deutsche Bank’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-22,408
| Closed | -$844K | – | 5011 |
|
|
2021
Q1 | $844K | Sell |
22,408
-6,987
| -24% | -$174K | ﹤0.01% | 2770 |
|
|
2020
Q4 | $501K | Buy |
29,395
+15,775
| +116% | +$198K | ﹤0.01% | 2900 |
|
|
2020
Q3 | $64K | Buy |
13,620
+1,292
| +10% | +$6.56K | ﹤0.01% | 3765 |
|
|
2020
Q2 | $75K | Buy |
12,328
+1,533
| +14% | +$6.32K | ﹤0.01% | 3606 |
|
|
2020
Q1 | $25K | Sell |
10,795
-1,108
| -9% | -$4.7K | ﹤0.01% | 3858 |
|
|
2019
Q4 | $53K | Sell |
11,903
-20,094
| -63% | -$79.6K | ﹤0.01% | 3948 |
|
|
2019
Q3 | $123K | Sell |
31,997
-162,044
| -84% | -$889K | ﹤0.01% | 3446 |
|
|
2019
Q2 | $1.17M | Buy |
194,041
+170,245
| +715% | +$1.63M | ﹤0.01% | 2741 |
|
|
2019
Q1 | $317K | Sell |
23,796
-92,605
| -80% | -$1.06M | ﹤0.01% | 3725 |
|
|
2018
Q4 | $1.08M | Sell |
116,401
-103,055
| -47% | -$1.23M | ﹤0.01% | 2830 |
|
|
2018
Q3 | $3.05M | Sell |
219,456
-32,432
| -13% | -$482K | ﹤0.01% | 2571 |
|
|
2018
Q2 | $3.98M | Sell |
251,888
-71,357
| -22% | -$1.25M | ﹤0.01% | 2473 |
|
|
2018
Q1 | $5.55M | Buy |
323,245
+182,922
| +130% | +$3.57M | ﹤0.01% | 2127 |
|
|
2017
Q4 | $3.07M | Buy |
140,323
+27,655
| +25% | +$889K | ﹤0.01% | 2426 |
|
|
2017
Q3 | $4.61M | Sell |
112,668
-210,430
| -65% | -$6.61M | ﹤0.01% | 1967 |
|
|
2017
Q2 | $9.73M | Sell |
323,098
-1,274
| -0.4% | -$39.8K | 0.01% | 1425 |
|
|
2017
Q1 | $11.7M | Buy |
324,372
+231,738
| +250% | +$10.2M | 0.01% | 1163 |
|
|
2016
Q4 | $4.64M | Sell |
92,634
-6,131
| -6% | -$322K | ﹤0.01% | 1706 |
|
|
2016
Q3 | $5.18M | Sell |
98,765
-40,040
| -29% | -$1.91M | ﹤0.01% | 1698 |
|
|
2016
Q2 | $5.74M | Buy |
138,805
+44,783
| +48% | +$1.95M | ﹤0.01% | 1656 |
|
|
2016
Q1 | $3.82M | Sell |
94,022
-61,993
| -40% | -$2.13M | ﹤0.01% | 1935 |
|
|
2015
Q4 | $6.47M | Buy |
156,015
+67,740
| +77% | +$2.27M | ﹤0.01% | 1612 |
|
|
2015
Q3 | $1.36M | Buy |
88,275
+876
| +1% | +$18.8K | ﹤0.01% | 2744 |
|
|
2015
Q2 | $2.17M | Buy |
87,399
+73,572
| +532% | +$1.64M | ﹤0.01% | 2387 |
|
|
2015
Q1 | $315K | Sell |
13,827
-9,974
| -42% | -$252K | ﹤0.01% | 3554 |
|
|
2014
Q4 | $640K | Buy |
23,801
+15,904
| +201% | +$274K | ﹤0.01% | 3513 |
|
|
2014
Q3 | $91K | Buy |
7,897
+1,813
| +30% | +$22.9K | ﹤0.01% | 4555 |
|
|
2014
Q2 | $94K | Sell |
6,084
-1,665
| -21% | -$23.9K | ﹤0.01% | 4599 |
|
|
2014
Q1 | $152K | Sell |
7,749
-44,749
| -85% | -$760K | ﹤0.01% | 4041 |
|
|
2013
Q4 | $880K | Buy |
+52,498
| New | +$652K | ﹤0.01% | 2742 |
|
Deutsche Bank's FPRX Position: Q2 2021 in Review
Deutsche Bank sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 22,408 shares — an estimated $844K sold.
Deutsche Bank first reported a position in FPRX in Q4 2013 and held it in 30 quarters. The position peaked at $11.7M in Q1 2017. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Deutsche Bank reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 22,408 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $844K.
- Deutsche Bank first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 30 quarters.
- Deutsche Bank's Five Prime Therapeutics, Inc. position peaked at $11.7M in Q1 2017.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.